The Future of Telemedicine in the Management of Heart Failure Patients

Data de publicação:

Autores da FMUP

  • José Carlos De Magalhães Silva Cardoso

    Autor

  • Emilia Da Conceição Torres Dias Moreira

    Autor

Participantes de fora da FMUP

  • Juanatey, JRG
  • Comin-Colet, J
  • Sousa, JM
  • Cavalheiro, A

Unidades de investigação

Abstract

Telemedicine (TM) is potentially a way of escalating heart failure (HF) multidisciplinary integrated care. Despite the initial efforts to implement TM in HF management, we are still at an early stage of its implementation. The coronavirus disease 2019 pandemic led to an increased utilisation of TM. This tendency will probably remain after the resolution of this threat. Face-to-face medical interventions are gradually transitioning to the virtual setting by using TM. TM can improve healthcare accessibility and overcome geographic inequalities. It promotes healthcare system efficiency gains, and improves patient self-management and empowerment. In cooperation with human intervention, artificial intelligence can enhance TM by helping to deal with the complexities of multicomorbidity management in HF, and will play a relevant role towards a personalised HF patient approach. Artificial intelligence-powered/telemedical/heart team/multidisciplinary integrated care may be the next step of HF management. In this review, the authors analyse TM trends in the management of HF patients and foresee its future challenges within the scope of HF multidisciplinary integrated care.

Dados da publicação

ISSN/ISSNe:
2057-7540, 2057-7559

Cardiac Failure Review  RADCLIFFE CARDIOLOGY

Tipo:
Article
Páginas:
11-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 30

Citações Recebidas na Scopus: 48

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Heart failure; telemedicine; multidisciplinary integrated care; telemonitoring; artificial intelligence

Financiamento

Proyectos asociados

Registo global de insuficiência cardíaca congestiva.

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Observacional Académico (IC_Congestiva) . 2019

This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms (EMPERIAL) - NCT03448406

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Ensaio Clínico Comercial (EMPERIAL) . Boehringer Ingelheim . 2020

Envolva-se com o seu coração: Promoção da adesão terapêutica com um sistema de telemonitorização para pessoas com insuficiência cardíaca crónica. (AdHeart)

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo de Intervenção Académico (AdHeart) . FCT . 2019

Sacubitril/Valsartan in everyday clinical practice: the experience of a heart failure clinic

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico (Sacubitril/Valsartan) . 2020

Avaliação da aorta ascendente em doentes operados a tetralogia de Fallot: implicações no follow-up clínico e imagiológico

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2020

Hyperkalemia as a limiting factor of Neurohormonal Blockade/Modulation in everyday clinical practice

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2020

Reversão da remodelagem ventricular na miocardiopatia dilatada idiopática

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação